Investigating the Use of Genetics to Guide Pharmacologic Therapy for Hypertension

PHASE2UnknownINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

June 30, 2022

Primary Completion Date

May 31, 2023

Study Completion Date

December 31, 2023

Conditions
Hypertension
Interventions
DRUG

Geneticure Panel for HTN therapy

Using either Genetics (Geneticure for HTN multi-gene panel) or JNC-8 guidelines for prescribing for patients with hypertension

DRUG

JNC-8

Using JNC-8 guidelines to guide therapy

Trial Locations (15)

55014

Fairview Clinics - Lino Lakes, Lino Lakes

55056

Fairview Clinics - North Branch, North Branch

55092

Fairview Clinics - Wyoming, Wyoming

55112

Fairview Clinic - New Brighton, New Brighton

55304

Fairview Health Clinics - Andover, Andover

55330

Fairview Health Clinics - Elk River, Elk River

55337

Fairview Clinics- Burnsville, Burnsville

55345

Fairview Health Clinics - Edina, Edina

55398

Fairview Health Services - Zimmerman, Zimmerman

55406

Fairview Clinics - Hiawatha, Minneapolis

55420

Fairview Health Clinics - Bloomington, Oxboro, Bloomington

55421

Fairview Clinics - Columbia Heights, Columbia Heights

55432

Fairview Clinics - Fridley, Fridley

55443

Fairview Clinics - Brooklyn Park, Brooklyn Park

55449

Fairview Health Clinics - Blaine, Blaine

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Fairview Health Services

OTHER

collaborator

University of Minnesota

OTHER

lead

Geneticure, LLC

INDUSTRY